Metabolic syndrome and mental illness
- PMID: 18041878
Metabolic syndrome and mental illness
Erratum in
- Am J Manag Care. 2008 Feb;14(2):76
Abstract
Patients with mental illnesses such as schizophrenia and bipolar disorder have an increased prevalence of metabolic syndrome and its components, risk factors for cardiovascular disease and type 2 diabetes. Although the prevalence of obesity and other risk factors such as hyperglycemia are increasing in the general population, patients with major mental illnesses have an increased prevalence of overweight and obesity, hyperglycemia, dyslipidemia, hypertension, and smoking, and substantially greater mortality, compared with the general population. Persons with major mental disorders lose 25 to 30 years of potential life in comparison with the general population, primarily due to premature cardiovascular mortality. The causes of increased cardiometabolic risk in this population can include nondisease-related factors such as poverty and reduced access to medical care, as well as adverse metabolic side effects associated with psychotropic medications, such as antipsychotic drugs. Individual antipsychotic medications are associated with well-defined risks of weight gain and related risks for adverse changes in glucose and lipid metabolism. Based on the medical risk profile of persons with major mental illnesses, and the evidence that certain medications can contribute to increased risk, screening and regular monitoring of metabolic parameters such as weight (body mass index), waist circumference, plasma glucose and lipids, and blood pressure are recommended to manage risk in this population. Treatment decisions should incorporate information about medical risk factors in general and cardiometabolic risk in particular. In addition to the implications for individual clinicians, the problem of disparity in meeting healthcare needs for persons with mental illness in comparison with the general population has become an important public policy concern, with recent recommendations from the National Association of State Mental Health Program Directors and the Institute of Medicine. This article provides an overview of cardiometabolic risk in patients with major mental illness and describes steps for risk reduction.
Similar articles
-
[Drawing up guidelines for the attendance of physical health of patients with severe mental illness].Encephale. 2009 Sep;35(4):330-9. doi: 10.1016/j.encep.2008.10.014. Epub 2009 Jul 9. Encephale. 2009. PMID: 19748369 French.
-
Antipsychotic medications: metabolic and cardiovascular risk.J Clin Psychiatry. 2007;68 Suppl 4:8-13. J Clin Psychiatry. 2007. PMID: 17539694 Review.
-
Comparing the safety and efficacy of atypical antipsychotics in psychiatric patients with comorbid medical illnesses.J Clin Psychiatry. 2009;70 Suppl 3:30-6. doi: 10.4088/JCP.7075su1c.05. J Clin Psychiatry. 2009. PMID: 19570499 Review.
-
Metabolic syndrome: epidemiology and consequences.J Clin Psychiatry. 2004;65 Suppl 18:3-12. J Clin Psychiatry. 2004. PMID: 15600380 Review.
-
Metabolic considerations in the use of antipsychotic medications: a review of recent evidence.J Clin Psychiatry. 2007;68 Suppl 1:20-7. J Clin Psychiatry. 2007. PMID: 17286524 Review.
Cited by
-
Health Care Utilization of Veterans With Serious Mental Illness.Fed Pract. 2017 Mar;34(Suppl 2):S14S-S19S. Fed Pract. 2017. PMID: 30766307 Free PMC article.
-
Metabolic Syndrome in First Episode Schizophrenia, Based on the National Mental Health Registry of Schizophrenia (NMHR) in a General Hospital in Malaysia: A 10-Year Retrospective Cohort Study.Int J Environ Res Public Health. 2018 May 7;15(5):933. doi: 10.3390/ijerph15050933. Int J Environ Res Public Health. 2018. PMID: 29735938 Free PMC article.
-
Feasibility, Adherence and Efficacy of Liraglutide Treatment in a Sample of Individuals With Mood Disorders and Obesity.Front Psychiatry. 2019 Jan 23;9:784. doi: 10.3389/fpsyt.2018.00784. eCollection 2018. Front Psychiatry. 2019. PMID: 30728788 Free PMC article.
-
Monitoring and prevalence rates of metabolic syndrome in military veterans with serious mental illness.PLoS One. 2011 Apr 26;6(4):e19298. doi: 10.1371/journal.pone.0019298. PLoS One. 2011. PMID: 21541294 Free PMC article.
-
Nonadherence with antipsychotic medication in schizophrenia: challenges and management strategies.Patient Relat Outcome Meas. 2014 Jun 23;5:43-62. doi: 10.2147/PROM.S42735. eCollection 2014. Patient Relat Outcome Meas. 2014. PMID: 25061342 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical